Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
InterAACT advanced anal cancer trial
2013-001949-13Phase 2Unknown
- Sponsor
- Royal Marsden NHS Foundation Trust
- Start
- Sep 2013
- Modality
- Small Molecules, DNA Intercalators/Alkylators → Nucleic Acid-Directed Small Molecules → Small Molecules, Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, open-label trial in anal squamous cell carcinoma (SCCA) comparing cisplatin + 5-fluorouracil with carboplatin + paclitaxel (2 arms). Primary endpoint: Best overall response rate. Status: unknown.
02
Drugs
cisplatinfluorouracilcarboplatinpaclitaxel
03
Conditions
anal squamous cell carcinoma (SCCA)
Beyond the preview
Go deeper on 2013-001949-13.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2013-001949-13.